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Objective: To assess the effectiveness and enlist clinical factors, which may affect the effectiveness of Pipelle 
sampling in diagnosing endometrial pathology in patients with abnormal uterine bleeding and Post-menopausal 
Bleeding. 
Study Design: ‘Analytical Cross-Sectional’ study. 
Place and Duration: Gynaecology Department at Combined Military Hospital Rawalpindi, in collaboration with 
Histo-Pathology Department, of six months duration i.e. from 1st  December 2019 to 31st May 2020. 
Material and Methods: 100 female patients of the outpatient department with presenting complaints of either 
abnormal or post-menopausal bleeding were included in the study in the specified time frame. After informed 
written consent, Pipelle endometrial sampling was done on an outpatient basis, and by consecutive sampling 
technique using the lottery method, the sample was sent for histopathological evaluation. Evaluated factors 
studied were:  indications for the procedure, age, parity, age of menarche. 
Results: Of the total patients evaluated, 91% (n=100) were non-malignant, while 4% (n=100) were malignant. 
Inadequate tissue was obtained in 5% of samples. The most common histopathological findings among the 
reproductive age group were Proliferative and Secretory phase endometrium 64% (n=100). While in the Post-
menopausal age group 4% (n=100) were Endometrial carcinoma on histopathology. Inadequate tissue samples 5% 
(n=100) were noted among the Post-menopausal group. 6% of samples showed endometrial hyperplasia. Pipelle 
Endometrial Sampling had sensitivity and specificity, in diagnosing the endometrial pathologies is summarized in 
Table 3. 
Conclusion: Pipelle Endometrial Sampling is an effective, safe, simple, and acceptable procedure for diagnosing 
endometrial pathology. It is cost-effective requiring no anesthesia with high sensitivity and specificity for 
detecting endometrial pathology. 
Keywords: Abnormal uterine bleeding, Pipelle endometrial sampling, Post-menopausal bleeding. 
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Introduction 
 
Abnormal uterine bleeding which was previously 
known as Dysfunctional uterine bleeding is irregular 
uterine bleeding with no recognized underlying 
uterine pathology.1 This disruption in the bleeding 
pattern is usually a result of hormonal imbalance. The 
bleeding pattern is unpredictable, it may be heavy or 
scanty inflow and it may be frequent, prolonged, or 
random in duration.2 One third of women attending 
gynecological outpatient clinics are with complaint of 
Abnormal uterine bleeding and the frequency of this 
problem increases in pre-menopausal and post-
menopausal years.3 Endometrial Sampling is 
recommended at forty years of age as the risk of 
Endometrial cancer is less than 1%under Under the 
age of 35 years and 6% prevalence is in women who 
are 45 years or less.4 Evaluation of Abnormal uterine 
bleeding in pre-menopausal women should be based 
on symptomatic and clinical presentation.5,6 
Endometrial Sampling is indicated even if the 
hysteroscopic findings are normal.7 
Endometrial Sampling is the gold standard for 
investigating patients with abnormal uterine bleeding. 
Pipelle endometrial sampling is now commonly 
performed in outpatient clinics, as it is safe, cheap, 
easy to perform requiring no indoor admission and 
anesthesia and it has no known major complications.8 
The main reason for performing Pipelle endometrial 
sampling is to differentiate between malignant and 
non-malignant pathology so that appropriate 
treatment can be started.9  
 
Materials and Methods 
 
This analytical cross-sectional study was conducted in 
Combined Military Hospital Rawalpindi, from 1st 
December 2019 to 31st May 2020. Permission of the 
hospital ethical committee was taken before 
conducting this study. A hundred women were 
included after taking the informed consent. A detailed 
history and examination were done in an outpatient 
gynecology clinic. Baseline investigations along with 
Pelvic ultrasound were advised. Pipelle Endometrial 
Sampling was performed by introducing Cusco’s 
speculum to visualize the cervix and pipelle was 
gently inserted in the uterine cavity, the inner sheath 
was withdrawn and it was rotated up and down. The 
endometrial tissue obtained was placed in a sample 
bottle containing 10% Formalin. The sample was then 
sent to the histopathology department of a hospital 
with proper labelling of the sample as well as brief 
clinical notes including patient age, history, and 
duration, and type of bleed was endorsed by the 
sampling physician. Report of Histopathology was 
collected from the histopathology department after 
specified days through the specific ID of all patients. 
All women above 40 years of age, with complaints of 
abnormal uterine bleeding and post-menopausal 
bleeding, were included in the study. The exclusion 
criteria were women with age less than 40 years, 
pregnancy, bleeding disorders, cervical stenosis, lower 
genital tract infections, hormonal intake, hormonal 
contraceptive history, and those taking anticoagulants. 
Eligible women were tested through a consecutive 
sampling method. All the relevant information was 
recorded on self-administered proformas. All data 
obtained were entered in MS Excel Sheet version 2019 
and statistical data was analyzed by using SPSS 
Software version 25. Descriptive analysis of both 
qualitative /quantitative variables was carried out, 
and frequencies were calculated. Risk factors were 
identified. Sensitivity, specificity, positive, and 
negative predictive values were calculated. Data was 
organized and presented in form of tables.  The 
analysis was significant at a 95% confidence interval 




During 06 months study period, about 100 patients 
underwent Pipelle Sampling for different menstrual 
cycle irregularity complaints. 68% of patients were in 
the age group of 40-50 years. 25% in 51-60 years and 
7% in 61-70 years of age group. 83% of patients had 
parity of P1-P4. 12% were nulli-para while 05% had 
parity of 5 or more. The age of menarche was 11-13 
years in 87% of patients and 13% fell in the 14-16 years 
of age group. All these statistics are shown in the table 
of demographic characteristics. The patients who 
underwent pipelle sampling. 27% had Post-
menopausal bleeding, 38% of patients with heavy 
menstrual bleeding. 26% had intermenstrual bleeding. 
09% presented with Post-cortical bleeding (shown in 
the tabulated form), 91% of histopathology samples 
were non-neoplastic, while 04% of samples were 
neoplastic. 05% of samples had scanty tissue which 
was not enough for diagnosis and they were in the 
Post-menopausal age group. Incidences of 
histopathological patterns are shown in Table 2. 
Proliferative endometrium 33% was the most common 
histopathological finding, indicating anovulation as 
the cause of abnormal uterine bleeding. Sensitivity, 
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specificity, positive, and negative predictive value for 
Pipelle was calculated for all histopathological 
samples, after excluding 05 inadequate samples. The 
Pipelle device was found to have 52% sensitivity, 100% 
specificity, 100% positive, and 94% negative predictive 
value for endometrial carcinoma. There were no 
complications noted with the said procedure except 
for a mild degree of discomfort. 
In this study, the Pipelle device was % accurate for 
diagnosing Proliferative, secretory phase, endometrial 
carcinoma, endometrial hyperplasia, and chronic 
endometritis. 
 
Table 1: Demographic Information of Patients 




Age Groups   
40-50 years 68 68% 
51-60 years 25 25% 
61-70 years 07 07% 
Parity    
Nullipara 12 12% 
P1-P5 83 83% 
≥P5 05 05% 
Age of menarche   
11-13 years 87 87% 
14-16 years 13 13% 
PRESENTING COMPLAINTS     
Post-menopausal bleeding    27 27% 
Intermenstrual bleeding 26 26% 
Heavy menstrual bleeding 38 38% 
Post-coital bleeding 09 09% 
 
Table 2: Histopathological results of Pipelle sampling (n=100) 
HISTOPATHOLOGICAL DIAGNOSIS NUMBER OF CASES 
n=100 
PERCENTAGE% 
Proliferative endometrium 33 33% 
Secretory endometrium 31 31% 
Chronic endometritis 13 13% 
Endometrial polyp 06 06% 
Senile atrophic endometrium 02 02% 
Scanty tissue 05 05% 
Endometrial hyperplasia without atypia 03 03% 
Endometrial hyperplasia with atypia 03 03% 
Endometrial carcinoma 04 04% 
 
Table 3: Effect modifier like Age stratification with the comparison of Efficacy of among both groups 
ENDOMETRIAL 
HISTOPATHOLOGY 






Proliferative endometrium 92% 100% 100% 97% 
Secretory endometrium 97% 99% 97% 99% 
Chronic endometritis 87% 100% 100% 98% 
Endometrial polyp 62% 100% 100% 89% 
Endometrial hyperplasia 
without atypia 
50% 96% 51% 96% 
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Endometrial hyperplasia 
with atypia 
78% 89% 50% 97% 
Endometrial carcinoma 52% 100% 100% 94% 
Discussion 
 
33% of the clientele attending the gynaecology clinic 
has the main complaint of Abnormal uterine 
bleeding.10 In females who are in the age bracket of 40 
years or more, it certainly is important to investigate 
this complaint to rule out any malignant entity and to 
confirm the benign nature of the disease and treat it 
accordingly.11 Previously Diagnostic Dilatation and 
curettage was the gold standard for investigating 
patients with Abnormal uterine bleeding, but the need 
for hospital admission, general anesthesia, and the cost 
has made it a less favorable option.12 Regarding 
outpatient diagnostic gynecological procedures, 
ultrasonography is one of the minimally invasive 
modalities which can avoid 40% of histological 
assessment of endometrium, although the cut-off limit 
for endometrial thickness is still not clear13, a thin 
regular endometrium is reliable in excluding 
endometrial carcinoma.14 The outpatient-based 
procedures are gaining popularity for quite some time 
because of their safety, cost-effectiveness, easy 
accessibility, and better patient acceptability e.g. 
Pipelle Sampling device, Vabra, and Z samples. Pipelle 
is a flexible, polypropylene device, which was 
introduced in the 1980s. It is a thin, plastic suction tube 
about 3mm in diameter with graduated markings 
designed on it.15 The most common presenting 
complaint in our study was heavy menstrual bleeding 
(38%) followed by post-menopausal bleeding (27%) 
which is in comparison to a study performed by 
Mathew et al16 and Samal et al17, where heavy 
menstrual bleeding was the leading complaint in the 
per-imenopausal age group. This is also supported by 
a similar study done by Muzaffar et al.18 The incidence 
of the non-neoplastic lesion in our study was 91% and 
4% were neoplastic lesions. This is similar to studies 
conducted by Mathew et al16, and Abdelazim IA et 
al20, and Chaudhary A et al19 where sample adequacy 
was 96%, 97.9%, and 95% respectively and in our 
study, the sample adequacy was 95%. There were 05 
cases of inadequate samples which is in comparison to 
a study conducted by Fakhar S et al9, where there were 
02 inadequate samples and a similar study by Mathew 
et al16 had 05 inadequate samples. In our study, these 
inadequate samples were in a post-menopausal age 
group. Proliferative endometrium was the commonest 
histopathological finding of 33% followed by secretory 
endometrium 31%. Endometrial hyperplasia with and 
without atypia 03% each. 13% were chronic 
endometritis and 06% were endometrial polyps on 
histopathology. These findings are in comparison to a 
study conducted by Samal K et al17, where similar 
findings were observed. 13% of chronic endometritis 
cases were observed in the reproductive age group. In 
this study, Pipelle was seen to have 100% specificity 
and positive predictive value, 52% sensitivity, and 94% 
negative predictive value for endometrial carcinoma 
and these findings are similar to a study done by 
Mathew et al16 where Pipelle showed 50% sensitivity 
and 100% specificity for detecting endometrial 
carcinoma. Our study showed 78% sensitivity, 89% 
specificity for endometrial hyperplasia with atypia 
with 50% positive, and 97% negative predictive value. 
This is similar to a study by Mathew et al16 and Sanam 
M et al.22 05 inadequate samples in our study were in 
the post-menopausal age group, they went on to have 
diagnostic dilation and curettage which showed 
atrophic endometrium on histopathology. This is 
comparable to a study done by Asif et al21 where 
inadequate samples were 04%. Pipelle Sampling is an 
effective tool in diagnosing endometrial pathology 





We conclude that Pipelle is a safe, cost-effective, and 
reliable device for diagnosing Endometrial pathologies 
especially endometrial carcinoma and hyperplasia. Its 
performance is better in diagnosing global endometrial 
pathology rather than focal pathology. In high-risk 
women, this procedure along with ultra-sound can 
achieve a reliable diagnosis. The time has come to base 
our diagnosis of different diseases through outpatient, 




It is a single-center study, done on a small sample size 
so it cannot be generalized. Taking this study as a 
reference point, future multi-centered research with a 
larger sample size is recommended.  
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